|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Time course of inhibition of caffeine elimination in response to the oral |
| depot contraceptive agent, Deposiston. Hormonal contraceptives and caffeine |
| elimination. [Zeitverlauf der Hemmung der Coffeinelimination unter dem |
| Einfluss des oralen Depotkontrazeptivum Deposiston. Hormonale Kontrazeptiva |
| Meyer FP; Canzler E; Giers H; Walther H |
| ZENTRALBLATT FUR GYNAKOLOGIE. 1991;113(6):297-302. |
| Over 6 months, the influence of the oral depot contraceptive Deposiston (3 mg ethinyl estradiol sulphonate + 10 mg |
| norethisterone acetate/menstrual cycle) on the pharmacokinetics of caffeine as a model substance was studied in 7 |
| women. The 1st examination began prior to the administration of the drug. The women were subjected to little |
| challenge as saliva was used as the basis of measurement. Deposiston was found to markedly delay the |
| elimination 1/2-life of caffeine (p<0.05): t 1/2 prior to therapy 4.9 +or- 2.6 hours and, after as little as 2 mg ethinyl |
| estradiol sulphonate, 8.0 +or- 3.5 hours. In contrast to the effect observed for preparations containing less estrogen, |
| these longer 1/2-lives persisted through the trial. As expected, the AUC values were slightly elevated during this |
| period, whereas clearance values were reduced. (summaries in GER, ENG) (PubHealth.info Document ID: CONT3T |
| PubHealth.info NOTE: The author(s) of this article titled, "Time course of inhibition of caffeine elimination in |
| response to the oral depot contraceptive agent, Deposiston. Hormonal contraceptives and caffeine elimination. |
| [Zeitverlauf der Hemmung der Coffeinelimination unter dem Einfluss des oralen Depotkontrazeptivum Deposiston. |
| Hormonale Kontrazeptiva und Coffeinelimination.]", is(are) Meyer FP; Canzler E; Giers H; Walther H. The source of |
| this article is "ZENTRALBLATT FUR GYNAKOLOGIE. 1991;113(6):297-302.". This article was published in 1991 in |
| German language(s). (PubHealth.info® Document ID: CONT3T 2027-06. All rights reserved with PubHealth.info) PIN: |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |